Sutro Biopharma

BuildersFirstsource

Wells Fargo

Wells Fargo Upgrades Sutro Biopharma to Overweight, Raises PT to $27.

Builders Firstsource's 15min chart shows Bollinger Bands narrowing, KDJ death cross.

Builders Firstsource: MACD Death Cross & Expanding Downward Bollinger Bands

United Therapeutics

Builders Firstsource

The Trade Desk

Mid-Cap Stocks for Long-Term Investors: 2 Picks and 1 to Avoid

Builders Firstsource 15min chart shows MACD Death Cross, Bollinger Bands Narrowing

Catalyst<ul> <li>Recent Long Upper Shadow and MACD Death Cross signals suggest potential for a rebound in momentum for BLDR.</li> <li>Fund flows show positive inflow trends for Medium and Large orders, indicating institutional confidence.</li> <li>Analysts have split their ratings with two Buy recommendations, reflecting some institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show conflicting signals such as MACD Golden Cross and Long Lower Shadow, suggesting market volatility and uncertainty.</li> <li>Analyst ratings are inconsistent and market expectations are pessimistic, indicating lack of clear consensus about BLDR's outlook.</li> <li>Fundamental factors including Revenue-MV and Cash-MV are negative, signaling potential valuation concerns.</li></ul>

Key Factors

Builders FirstSource (BLDR) ended the recent trading session at $84.49, demonstrating a -2.46% change from the preceding day's closing price.Builders FirstSource (BLDR) is one mid-cap stock to avoid due to annual sales declines and eroding returns on capital.

Recent Updates

BLDR News